Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$80.98 - $109.47 $51.4 Million - $69.5 Million
-635,302 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$82.78 - $101.0 $10.2 Million - $12.5 Million
-123,389 Reduced 16.26%
635,302 $55.9 Million
Q1 2021

May 17, 2021

SELL
$90.71 - $108.28 $46.4 Million - $55.4 Million
-511,838 Reduced 40.29%
758,691 $73.8 Million
Q4 2020

Feb 12, 2021

SELL
$92.08 - $124.48 $8.66 Million - $11.7 Million
-94,102 Reduced 6.9%
1,270,529 $142 Million
Q2 2020

Aug 14, 2020

SELL
$57.09 - $79.27 $14.2 Million - $19.7 Million
-248,663 Reduced 15.41%
1,364,631 $106 Million
Q1 2020

May 15, 2020

BUY
$48.11 - $82.22 $5.23 Million - $8.94 Million
108,695 Added 7.22%
1,613,294 $94.3 Million
Q4 2019

Feb 14, 2020

BUY
$66.73 - $82.59 $405,918 - $502,394
6,083 Added 0.41%
1,504,599 $121 Million
Q1 2019

May 15, 2019

BUY
$48.7 - $86.6 $3.29 Million - $5.85 Million
67,567 Added 4.72%
1,498,516 $120 Million
Q4 2018

Feb 14, 2019

BUY
$45.57 - $74.26 $65.2 Million - $106 Million
1,430,949 New
1,430,949 $77.1 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.77B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Hhlr Advisors, Ltd. Portfolio

Follow Hhlr Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Hhlr Advisors, Ltd. with notifications on news.